STOCK TITAN

TELA Bio, Inc. (TELA) CEO discloses 5,000-share ownership stake

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

TELA Bio, Inc. director and Chief Executive Officer Heather C. Getz filed an initial statement of beneficial ownership, reporting 5000.0000 shares of Common Stock held directly as of 2026-08-03. The filing also references an Exhibit 24 Power of Attorney authorizing certain SEC filing actions.

Positive

  • None.

Negative

  • None.
Insider Getz Heather C
Role Chief Executive Officer
Type Security Shares Price Value
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 5,000 shares (Direct)
Common stock holdings 5000.0000 shares Direct holdings reported for Heather C. Getz following the 2026-08-03 holding entry
Holding entries 1 Number of non-derivative holding entries reported in this Form 3
Net buy/sell shares 0 No net purchases or sales; only a holding position is disclosed
Common Stock financial
"security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Power of Attorney regulatory
"Exhibit 24 - Power of Attorney"
A power of attorney is a legal document that allows one person to make decisions and act on behalf of another person, often in financial or legal matters. It’s like giving someone a trusted helper or agent the authority to handle important tasks if you are unable to do so yourself. This matters to investors because it can impact how their assets are managed or transferred if they become unable to oversee their affairs.
transaction code regulatory
"transaction_code_description: Unknown transaction code"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does the Form 3 filing by TELA (TELA Bio, Inc.) report?

The Form 3 reports that CEO and director Heather C. Getz beneficially owns 5000.0000 shares of Common Stock of TELA Bio, Inc., held directly as of 2026-08-03, establishing her initial reported equity position as an insider.

How many TELA (TELA Bio, Inc.) shares does Heather C. Getz hold?

Heather C. Getz is reported to hold 5000.0000 shares of TELA Bio Common Stock. These shares are listed as a direct ownership position in the Form 3, with no accompanying purchase or sale transactions disclosed in this filing.

What is Heather C. Getz’s role at TELA (TELA Bio, Inc.) in this Form 3?

Heather C. Getz is identified as both a director and an officer, serving as Chief Executive Officer of TELA Bio, Inc. Her dual role is noted along with her initial reported direct holdings of common stock.

Does the TELA (TELA Bio, Inc.) Form 3 show any recent insider trades?

No trades are shown; the Form 3 presents a holding entry only. It lists 5000.0000 shares of Common Stock held directly after the reported date, with no buy, sell, exercise, or gift transactions indicated in this disclosure.

What is the significance of Exhibit 24 in TELA’s Form 3 for Heather C. Getz?

The Form 3 remarks reference an Exhibit 24 - Power of Attorney. This indicates that Heather C. Getz has authorized designated individuals to act on her behalf in connection with certain SEC filing matters related to her TELA Bio holdings.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Getz Heather C

(Last)(First)(Middle)
C/O TELA BIO, INC.
1 GREAT VALLEY PARKWAY, SUITE 24

(Street)
MALVERN PENNSYLVANIA 19355

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
08/03/2026
3. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock5,000D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Megan Smeykal, Attorney-in-Fact08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)